CSIMarket


Anebulo Pharmaceuticals Inc  (ANEB)
Other Ticker:  
 


 

Anebulo Pharmaceuticals Inc

ANEB's Financial Statements and Analysis



Anebulo Pharmaceuticals Inc increased I. Quarter net loss per share of $-0.11 compare to net loss per share of $-0.07 recorded in the same quarter a year ago a decrease compare to $-0.05 realized in previous quarter.


I. Quarter
Earnings Per Share Revenues
$ -0.11 $  0 Mill
$-0.04     Unch.    



Anebulo Pharmaceuticals Inc's Revenue fell by 0 % in I. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.


Anebulo Pharmaceuticals Inc is Expected to report next financial results on February 10, 2023.

More on ANEB's Income Statement



Anebulo Pharmaceuticals Inc's in I. Quarter recorded net loss of $-2.612 million, an increase from net loss of $-1.553 million in I. Quarter a year ago.

Sequentially net loss advanced

More on ANEB's Growth

ANEB's Cash flow In I. Quarter company's net cash flow was $5 million


Anebulo Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Anebulo Pharmaceuticals Inc payed $ -0.29 cash per share, on a free-cash flow basis .